For nearly a decade, Breakthrough T1D’s TypeOneNation Summits have brought together the type 1 diabetes (T1D) community through education and peer support.
During the COVID-19 pandemic, Breakthrough T1D’s Community Engagement team shifted to virtual TON Summits to ensure this essential support continued for people with T1D and their loved ones.
Now, with the return of in-person events and improved virtual event technology, TypeOneNation Summits are back with an exciting new approach to champion our community of supporters!
“TypeOneNation Summits are the cornerstone of our education program,” says Kristin Jahnke, Breakthrough T1D Associate Vice President of Community Engagement. “Our goal is to educate, connect, and inspire our community, wherever they may be on their T1D journey.”
In-Person Summits: An Opportunity for Reconnection
In-person TypeOneNation Summits will continue to feature educational talks from T1D experts, a vendor exhibition, and networking opportunities. The format will vary and offer unique elements geared to support the Summit’s theme.
- Full Summit events feature a keynote speaker and breakout sessions that are deep dives into T1D-centric topics.
- Meet and Greet Summits offer a Q&A panel or roundtable discussions led by local experts.
- Educational Summits are smaller events on one focused topic.
“Attendees will leave all of our 2023 Summits feeling informed and empowered,” Jahnke said.
Visit your local chapter page to find an in-person Summit near you.
Virtual Sessions Reimagined
The new TypeOneNation Summit virtual sessions will make it easier and more convenient for members of the T1D community to take part.
Previously held on a virtual event platform during the pandemic, guests will now be able to join the virtual sessions on Facebook, LinkedIn, YouTube, and other social media platforms.
“Our virtual sessions will be a great opportunity to hear from a variety of speakers, including leading national T1D experts, influencers, and community members,” Jahnke said. “They’ll also offer entertainment and interactive components to really bring the sessions to life.”
2023 TypeOneNation Summit Virtual Session Schedule
January
The 2023 TypeOneNation Summits virtually kick off on January 25, with January Jump Start: Real World Tips for Exercise & Nutrition with T1D, interactive discussions on exercise and nutrition, plus cooking and fitness demonstrations. Featured presenters include:
- Jordan Ligons, sports broadcast journalist (diagnosed with T1D at age 23)
- Jay T. Maryniak, fitness trainer (diagnosed with T1D at age 28)
- Breana Raquel, actor and recording artist (diagnosed with T1D in 2018)
- Michael Charles Riddell, Ph.D.; Professor, School of Kinesiology and Health Science, York University (diagnosed with T1D at age 15)
- Catherine Rogers, Ph.D., RDN, LD; Assistant Professor; Vice Chair for Education, Dept. of Nutrition, Case Western Reserve University (T1D since age 8)
March
On March 15, Breakthrough T1D honors Women’s History Month with a virtual session focused on women’s health issues such as relationships, body image, and pregnancy.
May
Breakthrough T1D recognizes Mental Health Awareness Month on May 11, with a virtual session that will explore strategies for coping and managing overall wellbeing. DiabetesSangha, an initiative within the diabetes online community to come together over meditation and contemplative practice, will also host an interactive session on mindfulness.
November
To close out 2023, the TypeOneNation Summit program will celebrate National Diabetes Awareness Month. The virtual session on November 14 will include a series of storytelling vignettes on topics important to the T1D community, such as health equity and access, research updates, and common concerns during the holiday season.
Visit Breakthrough T1D’s Community Summit webpage for more information and to register!
Special thanks to our 2023 TypeOneNation Summit sponsors:
Abbott | Ascensia Diabetes Care | Dexcom | Insulet | Lilly | MannKind
Medtronic | Provention Bio | Splenda | Tandem Diabetes Care
Vertex Pharmaceuticals | Xeris Biopharma